These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27099149)

  • 1. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome.
    Völkl S; Rensing-Ehl A; Allgäuer A; Schreiner E; Lorenz MR; Rohr J; Klemann C; Fuchs I; Schuster V; von Bueren AO; Naumann-Bartsch N; Gambineri E; Siepermann K; Kobbe R; Nathrath M; Arkwright PD; Miano M; Stachel KD; Metzler M; Schwarz K; Kremer AN; Speckmann C; Ehl S; Mackensen A
    Blood; 2016 Jul; 128(2):227-38. PubMed ID: 27099149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
    Rensing-Ehl A; Völkl S; Speckmann C; Lorenz MR; Ritter J; Janda A; Abinun M; Pircher H; Bengsch B; Thimme R; Fuchs I; Ammann S; Allgäuer A; Kentouche K; Cant A; Hambleton S; Bettoni da Cunha C; Huetker S; Kühnle I; Pekrun A; Seidel MG; Hummel M; Mackensen A; Schwarz K; Ehl S
    Blood; 2014 Aug; 124(6):851-60. PubMed ID: 24894771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
    Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
    Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7 Abrogates the Immunosuppressive Function of Human Double-Negative T Cells by Activating Akt/mTOR Signaling.
    Allgäuer A; Schreiner E; Ferrazzi F; Ekici AB; Gerbitz A; Mackensen A; Völkl S
    J Immunol; 2015 Oct; 195(7):3139-48. PubMed ID: 26324773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells.
    Juvet SC; Thomson CW; Kim EY; Han M; Zhang L
    PLoS One; 2013; 8(6):e65253. PubMed ID: 23762329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next Generation Sequencing for Detecting Somatic
    López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
    Front Immunol; 2021; 12():656356. PubMed ID: 33995372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expanded double negative T cell populations of a patient with ALPS are not clonally related to CD4+ or to CD8+ T cells.
    Marlies A; Udo G; Juergen B; Bernd S; Herrmann M; Haas JP
    Autoimmunity; 2007 Jun; 40(4):299-301. PubMed ID: 17516214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription factor eomesodermin.
    Kinjyo I; Gordon SM; Intlekofer AM; Dowdell K; Mooney EC; Caricchio R; Grupp SA; Teachey DT; Rao VK; Lindsten T; Reiner SL
    J Immunol; 2010 Dec; 185(12):7151-5. PubMed ID: 21076068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR signaling promotes a robust and continuous production of IFN-γ by human memory CD8+ T cells and their proliferation.
    Setoguchi R; Matsui Y; Mouri K
    Eur J Immunol; 2015 Mar; 45(3):893-902. PubMed ID: 25476730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS.
    Maccari ME; Fuchs S; Kury P; Andrieux G; Völkl S; Bengsch B; Lorenz MR; Heeg M; Rohr J; Jägle S; Castro CN; Groß M; Warthorst U; König C; Fuchs I; Speckmann C; Thalhammer J; Kapp FG; Seidel MG; Dückers G; Schönberger S; Schütz C; Führer M; Kobbe R; Holzinger D; Klemann C; Smisek P; Owens S; Horneff G; Kolb R; Naumann-Bartsch N; Miano M; Staniek J; Rizzi M; Kalina T; Schneider P; Erxleben A; Backofen R; Ekici A; Niemeyer CM; Warnatz K; Grimbacher B; Eibel H; Mackensen A; Frei AP; Schwarz K; Boerries M; Ehl S; Rensing-Ehl A
    J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33170215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of common variable immunodeficiency patients and healthy individuals using autoimmune lymphoproliferative syndrome biomarkers.
    Roberts CA; Ayers L; Bateman EA; Sadler R; Magerus-Chatinet A; Rieux-Laucat F; Misbah SA; Ferry BL
    Hum Immunol; 2013 Dec; 74(12):1531-5. PubMed ID: 23993982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 Influence mTOR to Modulate CD8
    Wang H; Li J; Han Q; Yang F; Xiao Y; Xiao M; Xu Y; Su L; Cui N; Liu D
    Int J Med Sci; 2017; 14(10):977-983. PubMed ID: 28924369
    [No Abstract]   [Full Text] [Related]  

  • 14. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
    Magerus-Chatinet A; Stolzenberg MC; Loffredo MS; Neven B; Schaffner C; Ducrot N; Arkwright PD; Bader-Meunier B; Barbot J; Blanche S; Casanova JL; Debré M; Ferster A; Fieschi C; Florkin B; Galambrun C; Hermine O; Lambotte O; Solary E; Thomas C; Le Deist F; Picard C; Fischer A; Rieux-Laucat F
    Blood; 2009 Mar; 113(13):3027-30. PubMed ID: 19176318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders.
    Oliveira Mendonça L; Matucci-Cerinic C; Terranova P; Casabona F; Bovis F; Caorsi R; Fioredda F; Palmisani E; Grossi A; Guardo D; Bustaffa M; Volpi S; Ceccherini I; Ravelli A; Dufour C; Miano M; Gattorno M
    Rheumatology (Oxford); 2022 Feb; 61(2):696-704. PubMed ID: 33909886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells.
    Ito D; Nojima S; Nishide M; Okuno T; Takamatsu H; Kang S; Kimura T; Yoshida Y; Morimoto K; Maeda Y; Hosokawa T; Toyofuku T; Ohshima J; Kamimura D; Yamamoto M; Murakami M; Morii E; Rakugi H; Isaka Y; Kumanogoh A
    J Immunol; 2015 Aug; 195(3):934-43. PubMed ID: 26116513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells.
    Henson SM; Franzese O; Macaulay R; Libri V; Azevedo RI; Kiani-Alikhan S; Plunkett FJ; Masters JE; Jackson S; Griffiths SJ; Pircher HP; Soares MV; Akbar AN
    Blood; 2009 Jun; 113(26):6619-28. PubMed ID: 19406987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal integration by Akt regulates CD8 T cell effector and memory differentiation.
    Kim EH; Sullivan JA; Plisch EH; Tejera MM; Jatzek A; Choi KY; Suresh M
    J Immunol; 2012 May; 188(9):4305-14. PubMed ID: 22467649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection.
    Staron MM; Gray SM; Marshall HD; Parish IA; Chen JH; Perry CJ; Cui G; Li MO; Kaech SM
    Immunity; 2014 Nov; 41(5):802-14. PubMed ID: 25464856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).
    Lisco A; Wong CS; Price S; Ye P; Niemela J; Anderson M; Richards E; Manion M; Mystakelis H; Similuk M; Lo B; Stoddard J; Rosenzweig S; Vanpouille C; Rupert A; Maric I; Perez-Diez A; Parenti D; Burbelo PD; Rao VK; Sereti I
    Front Immunol; 2019; 10():1193. PubMed ID: 31191551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.